Badgley Phelps Wealth Managers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Badgley Phelps Wealth Managers's PFE Position: Q3 2026 in Review
Badgley Phelps Wealth Managers increased its Pfizer (PFE) stake by 1.5% in Q3 2026, buying an estimated $21.9K and bringing the position to 56,906 shares worth $1.62M. The position accounts for 0.03% of the portfolio, ranked #174.
Badgley Phelps Wealth Managers first reported a position in PFE in Q3 2021 and has held it in 21 quarters since. The position peaked at $20M in Q4 2021. 1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Badgley Phelps Wealth Managers held 56,906 shares of Pfizer worth $1.62M as of Q3 2026.
- Badgley Phelps Wealth Managers bought 823 Pfizer shares in Q3 2026, an estimated $21.9K.
- Pfizer made up 0.03% of Badgley Phelps Wealth Managers's portfolio in Q3 2026, its #174 holding.
- Badgley Phelps Wealth Managers first reported a position in Pfizer in Q3 2021 and has held it in 21 quarters since.
- Badgley Phelps Wealth Managers's Pfizer position peaked at $20M in Q4 2021.
- 1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Badgley Phelps Wealth Managers's 13F filing for Q3 2026, filed 22 Oct 2026.